Navigation Links
SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
Date:5/13/2008

said Paul LaViolette, Chief Operating Officer of Boston Scientific. "With the anticipated FDA approval of the XIENCE V (PROMUS) Stent and the launch of the TAXUS Liberte Stent this year, we are excited to offer physicians and their patients two drugs on two highly deliverable platforms."

The PROMUS Stent is a private-labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific. The PROMUS and TAXUS Liberte(R) Stents have received CE Mark approval and are distributed in most European countries and other international markets. The XIENCE V (PROMUS) Stent is an investigational device in the U.S. and not yet approved for sale. It is currently under FDA review with an anticipated U.S. launch in 2008.

SPIRIT III is sponsored by Abbott. TAXUS, TAXUS Express2, Express, Liberte and PROMUS are trademarks of Boston Scientific Corporation or its affiliates. XIENCE is a trademark of Abbott Laboratories Group of Companies.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding clinical trials, product performance and competitive offering
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. SPIRIT II Explores Long-Term Performance of XIENCE V Stent
2. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
3. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
4. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
5. Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
6. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
7. DATATRAK International Reports First Quarter Results for 2008
8. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
9. Exelixis Announces First Quarter 2008 Financial Results
10. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
11. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Mass. , June 18, 2013 Decision Resources, ... pharmaceutical and healthcare issues, finds that, over the past 12 ... France , Germany , ... the United Kingdom ) have been required ... of their HIV patients, primarily to reduce costs. Additionally, more ...
(Date:6/18/2013)... , June 18, 2013 New-generation ... being highly portable and lightweight. Simultaneously, circuitry is ... the processing speed to which it performs at. ... medical electronics and military equipment, such as cameras ... Omnetics, micro-circular and nano-circular connectors include custom cable ...
(Date:6/18/2013)... 18, 2013 Remedy Informatics, a leading ... life sciences research, today announced it has been ... Schedule 70 supply contract (GS-35F-367AA, effective May 7, ... IT solutions to government agencies at federal, state ... Remedy has placed its products and services on ...
Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4
... Profil™ Institute for Clinical Research, Inc., a company specializing in early ... Marcus Hompesch , the company,s President and CEO, will serve as ... Diabetes, the American Diabetes Association,s ( ADA ) largest fund-raising event. ... Dr. Hompesch will help ...
... ROTTERDAM, The Netherlands , July 8, 2010 , ... - Novel Platform Set to Transform Human Therapeutic ... arGEN-X, ... proprietary SIMPLE,Antibody(TM) platform, announces that it has been granted the first patent,covering the platform. ...
Cached Medicine Technology:Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 2Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes 3arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 2arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 3arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 4
(Date:6/19/2013)... 19, 2013 According to Vanessa Grigoriadis, ... called “psychonauts” are creating new designer drugs featuring psychoactive ... of published documents and patented formulas. She reported her ... Now on June 4. , “Some of these ... never tested on humans. Maybe some of them are ...
(Date:6/19/2013)... The Report "Data Center Security Market [Logical ... UTM, IAM, SIEM, DR, ILM); Physical Security (PSIM, ... Forecasts & Analysis (2013-2018)", defines and segments the ... with in-depth analysis and forecasting of revenues. It ... with insights into trends, opportunities, and challenges. , ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Tools4ever, a ... sponsoring today's event, at which it will be giving ... well as giving further insight into its leading-edge solutions. ... IT & business professionals specialising in IDM infrastructure and ... of markets including the public sector, banking, finance and ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Recovery Associates, ... upon crystal meth addiction treatment, helping men and women ... drug. , Crystal meth is a stimulant named for ... drug is most commonly smoked, but it can also ... commonly created in homemade labs using common household ingredients ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The US ... test that has been specifically designed to help a recipient ... if their blood contains elevated levels of cobalt, and chromium, ... to see how the device is doing. In the event ... explain the possible options the person will need to consider, ...
Breaking Medicine News(10 mins):Health News:Dangerous Designer Drugs Dodge Legal System 2Health News:Dangerous Designer Drugs Dodge Legal System 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 2Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 3Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 4Health News:Crystal Meth Addiction Treatment and Crystal Meth Drug Rehab Announced by Recovery Associates 2Health News:US Drug Watchdog Now Urges Recipients Of A DePuy Pinnacle All Metal Hip Implant To Call Them About A Vital Blood Test To See If Their Hip Implant Device Has Failed 2
... want doctors to be ready to handle medical problems and ... //In the present state, what happens when a person develops ... back to normal conditions for treatment in time simply because ... from a UF study show there is little difference in ...
... has not yet been discovered. Currently,its diagnosis means, high-dose ... the cancer – a watch and wait approach. Recently, ... Belgium explored the possibility of providing patients with continuous ... be published in the November 15, 2006, issue of ...
... to open in Bihar as two US and six Indian ... ,"The Bihar State Investment Promotion Board (SIPB) has ... private sector," said a state official on condition of anonymity. ... in the health sector," he added. ,According to ...
... policymakers to ensure equal access to treatment and livelihood ... social vulnerability., ,"It is imperative to see that ... get equal opportunities to access treatment," stated the National ... on 'Gender impact of HIV and AIDS in India', ...
... million pounds have been pledged to mental hospitals around ... for inmates. A report published early this year by// ... incidents of attempted rape and specifically mentioned 19 incidents ... has catapulted this decision from the government. ...
... Infant Death Syndrome (SIDS) or 'cot death' that kills about ... a defect in the brain, scientists have said.// ... in the US compared the brains of cot death victims ... conditions. , ,They discovered a defect in the brain ...
Cached Medicine News:Health News:Researchers explore medicine in space 2Health News:Researchers explore medicine in space 3Health News:Fighting cancer - Multiple Myeloma with long-term therapy 2Health News:Equal Opportunities For HIV-Positive Women Urged 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: